The incidence of herpes zoster and herpes zoster ophthalmicus increase after age 50, and both are associated with an increased risk of cardiovascular complications. For patients ages 50 and older, the ...
Please provide your email address to receive an email when new articles are posted on . Antiviral treatment remains a cornerstone in preventing recurrence and reducing post-herpetic pain in herpes ...
Shingles is an infection nobody wants. Those who have endured the blistering rash describe the pain as searing, burning, or stabbing—sometimes lingering for months without relief. In severe cases, the ...
In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...
"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...
TUESDAY, Aug. 19, 2025 (HealthDay News) -- Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and ...
To systematically review and analyze reported cases of herpes zoster ophthalmicus (HZO)-related optic neuritis (ON) without retinal involvement, a potentially sight-threatening complication of ...
What is the aim of this review? The aim of this Cochrane Review was to find out if valacyclovir performs better than acyclovir in the treatment of a painful itchy rash caused by the chickenpox virus ...
This case is quoted, p. 78, in Dr. H. F. Damon's little book on Neurosis of the Skin, thus: "Dr. Williams, of Boston, has observed a case of inflammation of the eye from zoster frontalis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback